Associate Professor, Internal Medicine, University of Iowa College of Medicine
Endocrinology
Dr. Joseph S. Dillon, MD
|
|
Give Review
Joseph S. Dillon, MD practices Endocrinology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Joseph S. Dillon, MD has written publications. He has 27 publications published with PubMed. The lastest paper is: 'The human glucagon-like peptide-1 (GLP-1) receptor. Cloning and functional expression.'
Publications
- Hydrogen peroxide signaling mediates DHEA-induced vascular endothelial cell proliferation.
- Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms.
- Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and re...
- 20-carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors alpha and gamma.
- Dehydroepiandrosterone inhibits intracellular Calcium release in beta-cells by a plasma membrane-dependent mechanism.
- Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5'-monophosphate-dependent mechanism.
- Is there a receptor for dehydroepiandrosterone or dehydroepiandrosterone sulfate?
- Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 Diabetes.
- Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor.
- Effect of treatment of diabetic rats With dehydroepiandrosterone on vascular and neural function.
- Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3).
- UCP2-dependent proton leak in isolated mammalian mitochondria.
- Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception.
- Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor.
- The human glucagon-like peptide-1 (GLP-1) receptor. Cloning and functional expression.
- Glucagon-like peptide 1 stimulates lipolysis in clonal pancreatic beta-cells (HIT).
- Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.
- Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells.
- The recombinant rat glucagon-like peptide-1 receptor, expressed in an alpha-cell line, is coupled to adenylyl cyclase activation and intracellular Calcium release.
- Effects of adenoviral overexpression of uncoupling protein-2 and -3 on mitochondrial respiration in insulinoma cells.
- Glucagon-like peptide 1 and fatty acids amplify pulsatile insulin secretion from perifused rat islets.
- Severe metabolic bone Disease as a long-term complication of obesity surgery.
- Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells.
- Evaluation of a novel photoactive and biotinylated dehydroepiandrosterone analog.
- Synthesis and application of a photoaffinity analog of dehydroepiandrosterone (DHEA).
- Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological Disorders.
Schools
University College At Dublin National University Of Ireland
St Vincents Hospital
St Pauls Hospital
McGill University
Conditions Treated
- Abnormal Thyroid
- Adrenal Incidentaloma
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Choice Plus POS II
- American Enterprise Group
- American Republic
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Health Alliance PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Alliance Select
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University College of Dublin National Univ SOM
Drug Facts
| NPI NUMBER | 1710960026 | |
| NPPES Provider LastName | DILLON | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 522421009 | |
| NPPES Provider State | IA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 762.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710960026 |
| Last Name Of The Provider | DILLON |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
|
Dr. William I. Sivitz, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Cristina Ogrin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory C. Doelle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet A. Schlechte, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Swarna P. Rai, MD |
|
|
Dr. Caroline M. Houston, MD
This Doctor is OpenDoctor Recommended.
|